Literature DB >> 26873857

Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein-Coupled Receptor 120.

Rudi Prihandoko1, Elisa Alvarez-Curto1, Brian D Hudson1, Adrian J Butcher1, Trond Ulven1, Ashley M Miller1, Andrew B Tobin2, Graeme Milligan2.   

Abstract

It is established that long-chain free fatty acids includingω-3 fatty acids mediate an array of biologic responses through members of the free fatty acid (FFA) receptor family, which includes FFA4. However, the signaling mechanisms and modes of regulation of this receptor class remain unclear. Here, we employed mass spectrometry to determine that phosphorylation of mouse (m)FFAR4 occurs at five serine and threonine residues clustered in two separable regions of the C-terminal tail, designated cluster 1 (Thr(347), Thr(349), and Ser(350)) and cluster 2 (Ser(357)and Ser(361)). Mutation of these phosphoacceptor sites to alanine completely prevented phosphorylation of mFFA4 but did not limit receptor coupling to extracellular signal regulated protein kinase 1 and 2 (ERK1/2) activation. Rather, an inhibitor of Gq/11proteins completely prevented receptor signaling to ERK1/2. By contrast, the recruitment of arrestin 3, receptor internalization, and activation of Akt were regulated by mFFA4 phosphorylation. The analysis of mFFA4 phosphorylation-dependent signaling was extended further by selective mutations of the phosphoacceptor sites. Mutations within cluster 2 did not affect agonist activation of Akt but instead significantly compromised receptor internalization and arrestin 3 recruitment. Distinctly, mutation of the phosphoacceptor sites within cluster 1 had no effect on receptor internalization and had a less extensive effect on arrestin 3 recruitment but significantly uncoupled the receptor from Akt activation. These unique observations define differential effects on signaling mediated by phosphorylation at distinct locations. This hallmark feature supports the possibility that the signaling outcome of mFFA4 activation can be determined by the pattern of phosphorylation (phosphorylation barcode) at the C terminus of the receptor.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26873857     DOI: 10.1124/mol.115.101949

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  21 in total

Review 1.  Updates in the function and regulation of α1 -adrenoceptors.

Authors:  Juliana Akinaga; J Adolfo García-Sáinz; André S Pupo
Journal:  Br J Pharmacol       Date:  2019-04-01       Impact factor: 8.739

2.  Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates β-Arrestin Recruitment and Signaling to ERK1/2.

Authors:  Ilya S Senatorov; Ameneh Cheshmehkani; Rebecca N Burns; Kirti Singh; Nader H Moniri
Journal:  Mol Pharmacol       Date:  2020-03-04       Impact factor: 4.436

3.  Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells.

Authors:  Mandi M Hopkins; Ze Liu; Kathryn E Meier
Journal:  J Pharmacol Exp Ther       Date:  2016-07-29       Impact factor: 4.030

Review 4.  Structure and dynamics of GPCR signaling complexes.

Authors:  Daniel Hilger; Matthieu Masureel; Brian K Kobilka
Journal:  Nat Struct Mol Biol       Date:  2018-01-08       Impact factor: 15.369

Review 5.  G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms.

Authors:  Pierre-Yves Jean-Charles; Suneet Kaur; Sudha K Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2017-09       Impact factor: 3.105

6.  Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs.

Authors:  Sophie J Bradley; Colin Molloy; Paulina Valuskova; Louis Dwomoh; Miriam Scarpa; Mario Rossi; Lisa Finlayson; Kjell A Svensson; Eyassu Chernet; Vanessa N Barth; Karolina Gherbi; David A Sykes; Caroline A Wilson; Rajendra Mistry; Patrick M Sexton; Arthur Christopoulos; Adrian J Mogg; Elizabeth M Rosethorne; Shuzo Sakata; R A John Challiss; Lisa M Broad; Andrew B Tobin
Journal:  Nat Chem Biol       Date:  2020-02-20       Impact factor: 15.040

7.  GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery.

Authors:  Gabriele Carullo; Sarah Mazzotta; Margarita Vega-Holm; Fernando Iglesias-Guerra; José Manuel Vega-Pérez; Francesca Aiello; Antonella Brizzi
Journal:  J Med Chem       Date:  2021-04-10       Impact factor: 7.446

Review 8.  Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease.

Authors:  Debra A Kendall; Guillermo A Yudowski
Journal:  Front Cell Neurosci       Date:  2017-01-04       Impact factor: 5.505

9.  Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling.

Authors:  Elisa Alvarez-Curto; Asuka Inoue; Laura Jenkins; Sheikh Zahir Raihan; Rudi Prihandoko; Andrew B Tobin; Graeme Milligan
Journal:  J Biol Chem       Date:  2016-11-16       Impact factor: 5.157

10.  Docosahexaenoic acid mechanisms of action on the bovine oocyte-cumulus complex.

Authors:  Sebastien Elis; Mouhamad Oseikria; Anais Vitorino Carvalho; Priscila Silvana Bertevello; Emilie Corbin; Ana-Paula Teixeira-Gomes; Jérôme Lecardonnel; Catherine Archilla; Véronique Duranthon; Valérie Labas; Svetlana Uzbekova
Journal:  J Ovarian Res       Date:  2017-11-09       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.